These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23812933)

  • 1. Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Marcos-Gragera R
    Haematologica; 2013 Aug; 98(8):e95-7. PubMed ID: 23812933
    [No Abstract]   [Full Text] [Related]  

  • 2. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R
    Leuk Lymphoma; 2015 Apr; 56(4):896-902. PubMed ID: 25058372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries.
    Solans M; Sanvisens A; Ameijide A; Merino S; Rojas D; Alemán A; Banqueri E; Chico M; Marcos AI; de Castro V; Gil L; de Munain AL; Puigdemont M; Sánchez MJ; Perucha J; Ruiz-Armengol P; Chirlaque MD; Guevara M; Carulla M; Marcos-Gragera R
    Sci Rep; 2022 Jan; 12(1):323. PubMed ID: 35013373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of haematological neoplasms in Castilla y León, Spain].
    Rodríguez-García JA; Vázquez L; Ramos F; Cuevas B; Martín A; Smucler A; Guerola DN; Cantalapiedra A; Alonso JM; Fernández S; Díez E; Rodríguez MJ; Calmuntia MJ; Aguilar C; Sierra M; Gracia JA; Cebeira MJ; Cantalejo R;
    Med Clin (Barc); 2015 Jun; 144(11):491-500. PubMed ID: 25015251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study.
    Frederiksen H; Farkas DK; Christiansen CF; Hasselbalch HC; Sørensen HT
    Blood; 2011 Dec; 118(25):6515-20. PubMed ID: 22039256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
    Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
    Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map.
    Shallis RM; Wang R; Davidoff A; Ma X; Podoltsev NA; Zeidan AM
    Blood Rev; 2020 Jul; 42():100706. PubMed ID: 32517877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
    Holst JM; Plesner TL; Pedersen MB; Frederiksen H; Møller MB; Clausen MR; Hansen MC; Hamilton-Dutoit SJ; Nørgaard P; Johansen P; Ramm Eberlein T; Mortensen BK; Mathiasen G; Øvlisen A; Wang R; Wang C; Zhang W; Beier Ommen H; Stentoft J; Ludvigsen M; Tam W; Chan WC; Inghirami G; d'Amore F
    Haematologica; 2020 Oct; 105(10):2432-2439. PubMed ID: 33054083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based incidence of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain.
    Solans M; Fàbrega A; Morea D; Auñon-Sanz C; Granada I; Roncero JM; Blanco A; Kelleher N; Buch J; Saez M; Marcos-Gragera R
    Cancer Epidemiol; 2019 Feb; 58():8-11. PubMed ID: 30423540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014.
    Baade PD; Ross DM; Anderson LA; Forsyth C; Fritschi L
    Am J Hematol; 2019 Apr; 94(4):E107-E109. PubMed ID: 30663086
    [No Abstract]   [Full Text] [Related]  

  • 11. Coverage and accuracy of myeloproliferative and myelodysplastic neoplasms in the Finnish Cancer Registry.
    Leinonen MK; Rantanen M; Pitkäniemi J; Malila N
    Acta Oncol; 2016 Jun; 55(6):782-6. PubMed ID: 26767306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide population-based cross-sectional comparison of hematological malignancies incidences between Taiwan and the United States of America.
    Wu SJ; Chiang CJ; Lin CT; Tien HF; Lai MS
    Ann Hematol; 2016 Jan; 95(1):165-167. PubMed ID: 26407678
    [No Abstract]   [Full Text] [Related]  

  • 14. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.
    Sant M; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Visser O; Marcos-Gragera R; Maynadié M; Simonetti A; Lutz JM; Berrino F;
    Blood; 2010 Nov; 116(19):3724-34. PubMed ID: 20664057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study.
    Girodon F; Bonicelli G; Schaeffer C; Mounier M; Carillo S; Lafon I; Carli PM; Janoray I; Ferrant E; Maynadié M
    Haematologica; 2009 Jun; 94(6):865-9. PubMed ID: 19377078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second cancers in chronic myeloproliferative neoplasms.
    Susini MC; Masala G; Antonioli E; Pieri L; Guglielmelli P; Palli D; Bosi A; Vannucchi AM
    Blood; 2012 Apr; 119(16):3861-2; author reply 3862-3. PubMed ID: 22517876
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study.
    Hultcrantz M; Wilkes SR; Kristinsson SY; Andersson TM; Derolf ÅR; Eloranta S; Samuelsson J; Landgren O; Dickman PW; Lambert PC; Björkholm M
    J Clin Oncol; 2015 Jul; 33(20):2288-95. PubMed ID: 26033810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.
    Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Ouarzane M; Bellaoui M
    BMC Cancer; 2016 Feb; 16():159. PubMed ID: 26915519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004-2013.
    Oelofse D; Truter I
    Cancer Epidemiol; 2018 Apr; 53():166-171. PubMed ID: 29462765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.